![]() ![]() The patients in the fluconazole group reported less inconvenience from taking the medication, a finding that may have clinical implications for compliance. These differences were not found to be statistically significant. ![]() Eight patients in the fluconazole group and 12 patients in the nystatin group exhibited a relapse within 6 months. Half of the patients in the nystatin group reported inconvenience from taking the medication (mean value = 25.9) compared with 23% of the patients in the fluconazole group (mean value = 6.6). The comparable figures for the nystatin group were 10 of 12 patients (83%). I do not recommend the use of nystatin swish and swallow due to the high sugar content, potential nausea (which you have already experienced and relative ineffectiveness. Following treatment with fluconazole, 20 of 22 patients with symptoms at the start (91%) reported improvement. 1 star 62 Read more Patient Condition: Candida Fungus Infection of Mouth, Skin, Nails or Vagina Overall rating 5. ![]() The corresponding figure for the nystatin group (n = 30), rinsing with 1 mL 4 times a day for 21 days, was 80%. After 7 days of treatment with fluconazole (50 mg/day), the affected oral mucosa, assessed by the investigator, was cured or showed considerable improvement in 87% of the patients (n = 30). One patient who was treated with nystatin was excluded owing to nausea that was related to the antifungal treatment. results showed that after 7 days of nystatin oral suspension therapy only one patient (16) presented clinical cure, whereas four patients (66) treated with. For the remaining patients no specific predisposing factors were found. Predisposing factors were xerostomia (n = 18), HIV (n = 5), immunosuppression in conjunction with organ transplantation (n = 10), and wearing of dentures (n = 14). Of the included patients (n = 60), two-thirds presented with an erythematous candidosis, and the others showed clinical signs compatible with a pseudomembranous candidosis. The efficacy of oral fluconazole versus nystatin was evaluated as a treatment modality for oral candidosis. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |